Patients Coming Off Anti-Obesity Medications Put On Pounds Far More Rapidly Compared to People Using Diet and Exercise

New research suggests that patients who discontinue blockbuster weight-loss injections like semaglutide or tirzepatide may regain shed pounds at a significantly accelerated pace than those who stop traditional lifestyle regimens.

Published data in a prominent medical journal demonstrates that while obese individuals frequently drop a large proportion of their total mass while undergoing treatment, the weight returns at an estimated rate of nearly a kilo each month after stopping.

"People buying these treatments should be informed of the risk of quick weight regain when the therapy concludes," stated lead investigator Dr. Susan Jebb.

Such speed of recovery suggests a reversion to starting weight in about a year and a half.

Analyzing Approaches

The study, which reviewed dozens of trials involving thousands of participants, contrasted the outcomes of GLP-1 agonists with older methods.

Researchers note that individuals who lose weight through diet and exercise typically experience a more gradual creep back—around 0.1 kg a month—post-intervention.

Explaining the Fast Regain

Nutrition scientists suggest the mode of action of the drugs is key to understanding the amplified regain.

The injections copy a body's own chemical called GLP-1, which moderates hunger.

"Long-term administration of the hormone concentrations far above than normal may cause the body to produce less of its endogenous hormone, and may also diminish sensitivity to its effects," explained Dr. Adam Collins, a nutrition researcher.

"Withdrawal of this medication results in appetite is uncontrolled, making binge eating a significant risk."

A Lifelong Condition?

Health authorities advise the injections for people with weight-linked health risks, alongside prescribed lifestyle changes.

Many experts argue that, due to the likelihood of relapse, the therapy is often life-long.

This view is reinforced by pharmaceutical companies, who note that the findings "emphasize the chronic character of obesity," akin to managing diseases like diabetes.

User Accounts

People who have stopped the jabs explain a intense resurgence of cravings.

"I experienced something flipping and you're instantly starving," said one woman.

This challenge is worsened if patients have not established permanent lifestyle or habit changes during therapy.

Significant Adoption

Survey data suggest that millions of people in the UK have used weight-loss jabs in the last 12 months, with desire being substantial.

• Adoption is greater among women compared to men.
• The middle-aged demographic shows the highest usage rates.
• A large proportion obtain the drugs through private prescriptions rather than the NHS.

In conclusion, clinicians emphasize that while these medications are effective tools for weight loss, they are not a magic solution and lasting health benefits hinges on integrated behavioural management.